Skip to main content

Table 2 Interferon-γ production by cytotoxic T lymphocyte lines after incubation on anti-hamster IgG or anti-CD3 in the presence or absence of Lip-OspA, Met-Asp-Pro-OspA, recombinant interleukin-2 or lipopolysaccharide

From: Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease

Addition

B6 anti-BALB/c, ng/ml (SI)

TLR-2-/- anti-BALB/c, ng/ml (SI)

Anti-haIgG

0.2

0.3

   + Lip-OspA

2.3a (11.5)

0.2 (<1)

   + MDP-OspA

0.3 (1.5)

0.2 (<1)

   + rec. IL-2

0.5 (2.5)

0.4 (1.3)

   + LPS

0.2 (1.0)

0.4 (1.3)

0.03 ng per well anti-CD3

0.2

0.3

   + anti-CD3 + Lip-OspA

5.4a (27)

0.2 (<1)

   + anti-CD3 + MDP-OspA

0.2 (1.0)

0.3 (1.0)

   + anti-CD3 + rec. IL-2

0.8a (4.0)

0.6 (2.0)

   + anti-CD3 + LPS

0.3 (1.5)

0.1 (<1)

0.3 ng per well anti-CD3

4.9

7.2

   + anti-CD3 + Lip-OspA

29.1a (5.9)

6.8 (<1)

   + anti-CD3 + MDP-OspA

6.0 (1.2)

9.5 (1.3)

   + anti-CD3 + rec. IL-2

10.9a (2.2)

10.2 (1.4)

   + anti-CD3 + LPS

2.7 (<1)

7.2 (1.0)

  1. aSignificant difference (P < 0.05) from control (anti-haIgG or anti-CD3 without supplements). C57BL/6 (B6) and Toll-like receptor (TLR)-2-/- cytotoxic T lymphocyte lines (generated against BALB/c, fourth stimulation, day 4) were incubated for 6 h on anti-haIgG (control) with or without anti-CD3 (0.03 ng per well or 0.3 ng per well) in the presence or absence of Lip-OspA, Met-Asp-Pro (MDP)-OspA (10 μg/ml each), recombinant interleukin-2 (rec. Il-2; 50 U/ml) or lipopolysaccharide (LPS; 1 μg/ml). The amount of the secreted interferon-γ in the supernatant was then tested in duplicate using the enzyme-linked immunosorbent assay technique. One representative experiment is shown. The detection limit was 0.1 ng/ml. SI, stimulation index (calculated based on results with anti-hamster (ha)IgG plus anti-CD3 or anti-haIgG alone, without the addition of supplements).